Kurt Van der Speeten

Early- and Long-Term Outcome Data of Patients With Pseudomyxoma Peritonei From Appendiceal Origin Treated by a Strategy of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

Terence C. Chua, Brendan Moran, Paul H. Sugarbaker et al. · Journal of Clinical Oncology · 2012 · 1.1K citations · Full text

Medicine, Oncology, Surgery +14

The Role of Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei After Cytoreductive Surgery

Shigeki Kusamura, Francesco Barretta, Yutaka Yonemura et al. · JAMA Surgery · 2021 · 169 citations · Full text

Medicine, Oncology, Surgery +10

Peritoneal mesothelioma: PSOGI/EURACAN clinical practice guidelines for diagnosis, treatment and follow-up

Shigeki Kusamura, Vahan Képénékian, Laurent Villeneuve et al. · European Journal of Surgical Oncology · 2020 · 123 citations

Medicine, Oncology, Surgery +9

The Treatment of Peritoneal Carcinomatosis of Colorectal Cancer with Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Peroperative Chemotherapy (HIPEC) with Oxaliplatin: A Belgian Multicentre Prospective Phase II Clinical Study

Daphne Hompes, André D’Hoore, Eric Van Cutsem et al. · Annals of Surgical Oncology · 2012 · 110 citations

Medicine, Oncology, Surgery +12

Laparoscopic hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) in the management of refractory malignant ascites: A multi‐institutional retrospective analysis in 52 patients

Mario Valle, Kurt Van der Speeten, A. Garofalo · Journal of Surgical Oncology · 2009 · 103 citations

Medicine, Oncology, Surgery +12